Which causes more weight gain, Celexa (citalopram) or Lexapro (escitalopram)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Weight Gain Comparison: Celexa vs Lexapro

Lexapro (escitalopram) causes slightly more weight gain than Celexa (citalopram), though the difference is modest—approximately 0.3 kg more at 6 months.

Direct Comparative Evidence

The most robust head-to-head comparison comes from a large-scale 2024 target trial emulation study involving 183,118 patients across 8 U.S. health systems 1. This study provides the highest quality evidence for your question:

  • Escitalopram (Lexapro) was associated with 0.41 kg greater weight gain at 6 months compared to sertraline as the reference 1
  • Citalopram (Celexa) was associated with only 0.12 kg greater weight gain at 6 months compared to sertraline 1
  • The difference between them is approximately 0.29 kg (about 0.6 pounds) over 6 months, with escitalopram causing more weight gain 1

Risk of Clinically Significant Weight Gain

Beyond mean weight change, the probability of gaining ≥5% of baseline body weight matters more clinically:

  • Escitalopram increased the risk of ≥5% weight gain by 10-15% compared to sertraline 1
  • Citalopram showed minimal increased risk for this threshold 1

Additional Supporting Evidence

An 8-month head-to-head trial comparing escitalopram with duloxetine found that escitalopram was associated with significantly more weight gain (+1.83 kg) compared to duloxetine (+0.61 kg) at 8 months 2. While this doesn't directly compare to citalopram, it confirms escitalopram's propensity for weight gain among SSRIs.

A 2011 study comparing escitalopram to nortriptyline found minimal weight change with escitalopram (average increase of 0.14 kg over 12 weeks, representing a 0.05-point BMI increase) 3. This positions escitalopram as relatively weight-neutral compared to tricyclics, though still associated with some weight gain.

Clinical Context Within SSRI Class

According to the American Gastroenterological Association, within the SSRI class 4:

  • Paroxetine has the highest risk of weight gain among all SSRIs 4
  • Fluoxetine and sertraline typically cause initial weight loss followed by weight neutrality with long-term use 4
  • Escitalopram and citalopram fall in the middle, with escitalopram slightly worse than citalopram 1

Practical Clinical Algorithm

When weight is a concern in patients requiring antidepressant therapy 4:

  1. First choice: Bupropion (if no contraindications such as seizure disorders or eating disorders) - consistently associated with weight loss 4, 1
  2. Second choice: Fluoxetine or sertraline - weight-neutral to modest initial loss 4
  3. Third choice: Citalopram - minimal weight gain 1
  4. Fourth choice: Escitalopram - modest weight gain 1
  5. Avoid: Paroxetine, mirtazapine, amitriptyline - highest weight gain risk 4

Important Caveats

  • The absolute difference between citalopram and escitalopram is clinically small (less than 0.3 kg at 6 months) 1
  • Individual patient responses vary considerably, and baseline weight status influences outcomes 3
  • Medication adherence was low in the comparative study (28-41% at 6 months), which may underestimate true effects 1
  • Weight monitoring should occur at baseline, monthly for 3 months, then quarterly during continued treatment 4

References

Research

Changes in body weight during pharmacological treatment of depression.

The international journal of neuropsychopharmacology, 2011

Guideline

Antidepressant-Associated Weight Changes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.